-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 5, Fosun Pharma suffered a heavy decline in its stock price after experiencing a storm of shareholder reduction, and the A-share market value was closed in the afternoon, and the market value of the day was estimated to evaporate by 10.
The sharp decline in the share price is related to the announcement of the shareholding reduction plan by the controlling shareholder of
According to Fosun Pharma's announcement on September 2, the controlling shareholder, Shanghai Fosun Hi-Tech (Group) Co.
This is the first time that the controlling shareholder, Shanghai Fosun Hi-Tech (Group) Co.
The reduction is not the usual high-level reduction, Fosun Pharma's stock price has fallen by nearly 60% in the past year, and the total market value has evaporated by about 140 billion yuan
Fosun Pharma accelerates R&D innovation, Fosun Pharma's official website map
Fosun Pharma accelerates R&D innovation, Fosun Pharma's official website mapIt is worth noting that Fosun Pharma's R&D investment in the first half of this year still exceeded 11% of the total operating income, and the storm of reduction was related
The storm of the reduction of holdings is related
If you add the reduction of Fosun Pharma's shares, since the beginning of this year, "Fosun Galaxy" has intensively reduced its holdings of a number of listed companies, with a cumulative cash amount of more than 6 billion yuan